SMAD4 and intestinal cancer: Smad4 haploinsufficiency reportedly affects mouse intestinal tumorigenesis and progression and Smad4 deletion in combination with genetic alterations in antigen‐presenting cell (APC) results in intestinal cancer in mice.9, 10